# A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin

> **NCT00759941** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 86 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Brinzolamide 1% ophthalmic solution (Azopt)
- **DRUG:** Placebo eye drops
- **DRUG:** Latanoprost 0.005% ophthalmic solution (Xalatan)

## Key facts

- **NCT ID:** NCT00759941
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2014-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00759941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00759941, "A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00759941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*